# a Study of JY09 in Chinese Healthy Subjects

> **NCT02971722** · PHASE1 · UNKNOWN · sponsor: **Beijing Dongfang Biotech Co., Ltd.** · enrollment: 26 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JY09
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02971722
- **Lead sponsor:** Beijing Dongfang Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2017-05
- **Final completion:** 2018-03
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2016-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02971722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02971722, "a Study of JY09 in Chinese Healthy Subjects". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02971722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*